|
Complaint submitted through clinical data collection site.Limited information provided.Patient underwent posterolatoeral spinal surgery on (b)(6) 2024.The bia-gen moldable bone graft matrix product was placed in vertebrae location l4-l5.Auograft and other hardware (not manufactured or distributed by collagen matrix, inc.) were used in conjunction with the bia-gen product.A tlif and laminectomy were reported as other concomitant medical treatment.There were no complications noted during the initial procedure and the clinician noted the bia-gen product performed and handled excellent.On (b)(6) 2024 during a planned follow-up visit, it was noted the patient fell (exact details of fall not specified or provided), with injury to her leg and back, and has had worsening back pain since falling.A ct scan and mri was performed on patient, indicating lower back pain with some radicular component.The patient was prescribed medication (oxycodone; dosage not specified), physical therapy, and rest.Clinician noted they did not consider this to be a serious adverse event, and the reported event is not related to the bia-gen product.No additional information surrounding patient status, patient outcome, or even information will be provided.
|